Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Composite western medicine formula for treating gout

A western medicine and formula technology, applied in the field of western medicine compound formulations for the treatment of gout, can solve the problems of increased harmful heavy metal ions, low treatment effect of reducing uric acid, endangering the health of patients, etc., so as to protect gastric mucosa, promote human body detoxification, and promote cell regeneration. band effect

Inactive Publication Date: 2016-04-06
杜玉茗
View PDF2 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] In recent years, the number of patients with gout has been increasing. Gout is a disease caused by increased purine biosynthesis and metabolism, excessive uric acid production or poor excretion of uric acid, resulting in elevated uric acid in the blood. recurrent inflammatory diseases caused by bursa, cartilage and other tissues. However, most of the traditional gout drugs only have anti-inflammatory and analgesic effects, and the therapeutic effect on reducing uric acid is very low, which leads to patients with gout. At the same time, many drugs for the treatment of gout are more harmful to the gastrointestinal tract of patients, especially for some patients with gastric ulcer, the side effects are more obvious, and because the patients take the drugs for the treatment of gout for a long time, it is easy to cause accumulation in the human body The harmful heavy metal ions are gradually increasing, which greatly endangers the health of patients.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] Sucralfate 0.5g per capsule, Diclofenac Sodium 0.2g per capsule, Magnesium Oxide 0.1g per capsule, Benzbromarone 0.3g per capsule, Chitin 1.5g per capsule.

[0019] The preparation method is as follows: separately drying sucralfate, diclofenac sodium, magnesium oxide, benzbromarone and chitin, pulverizing, screening through a 250-mesh sieve, mixing uniformly, sterilizing, and packing into hard capsules.

Embodiment 2

[0021] Sucralfate 0.2g per capsule, Diclofenac Sodium 0.01g per capsule, Magnesium Oxide 0.01g per capsule, Benzbromarone 0.1g per capsule, Chitin 0.2g per capsule.

[0022] The preparation method is as follows: separately drying sucralfate, diclofenac sodium, magnesium oxide, benzbromarone and chitin, pulverizing, screening through a 250-mesh sieve, mixing uniformly, sterilizing, and packing into hard capsules.

Embodiment 3

[0024] Sucralfate 0.3g per capsule, Diclofenac Sodium 0.1g per capsule, Magnesium Oxide 0.05g per capsule, Benzbromarone 0.2g per capsule, Chitin 0.8g per capsule.

[0025] The preparation method is as follows: separately drying sucralfate, diclofenac sodium, magnesium oxide, benzbromarone and chitin, pulverizing, screening through a 250-mesh sieve, mixing uniformly, sterilizing, and packing into hard capsules.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a composite western medicine formula for treating gout. The composite western medicine is prepared from, by weight per granule, 0.2-0.5 g of sucralfate, 0.01-0.2 g of diclofenac sodium, 0.01-0.1 g of magnesium oxide, 0.1-0.3 g of benzbromarone and 0.2-1.5 g of chitin. According to the composite western medicine formula for treating the gout, the good gout treatment using effect is achieved; the activity of xanthine oxidase can be inhibited by using the benzbromarone, and therefore the concentration of uric acid in human blood is effectively lowered; by using the sucralfate, a layer of a protective film is formed to cover the ulcer surface, the effect of protecting the gastric mucosa is achieved, the using side effects of medicine on patients suffering from gastric ulcer and the like are effectively reduced, and meanwhile the effects of eliminating inflammation and relieving pain are obvious; by using the chitin, the effects of activating cells in a human body, preventing cell aging, promoting a newly-born cell band, adsorbing harmful heavy metal ions in the body, promoting human body detoxifying and the like can be achieved; gout patients can be effectively treated, and use is very convenient.

Description

technical field [0001] The invention belongs to the field of pharmaceutical formulations, in particular to a compound formulation of western medicine for treating gout. Background technique [0002] In recent years, the number of patients with gout has been increasing. Gout is a disease caused by increased purine biosynthesis and metabolism, excessive uric acid production or poor excretion of uric acid, resulting in elevated uric acid in the blood. recurrent inflammatory diseases caused by bursa, cartilage and other tissues. However, most of the traditional gout drugs only have anti-inflammatory and analgesic effects, and the therapeutic effect on reducing uric acid is very low, which leads to patients with gout. At the same time, many drugs for the treatment of gout are more harmful to the gastrointestinal tract of patients, especially for some patients with gastric ulcer, the side effects are more obvious, and because the patients take the drugs for the treatment of gout f...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K33/08A61P19/06A61K31/196A61K31/343A61K31/722A61K31/7024
CPCA61K33/08A61K31/196A61K31/343A61K31/722A61K2300/00
Inventor 杜玉茗李小囡马光力
Owner 杜玉茗
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products